Linda R. Duska, MD, MPH - Chair’s Take on Advances in Gynecologic Cancer Care: Exploring New Advances and Innovative Therapies in Endometrial and Cervical Cancers - a podcast by PVI, PeerView Institute for Medical Education
from 2020-07-10T18:00
Go online to PeerView.com/VSK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Watch Dr. Duska provide a brief recap of recent developments in endometrial and cervical cancer management, including evidence presented at the 2020 American Society of Clinical Oncology Annual Meeting. Dr. Duska comments on these findings and offers thoughts on new and emerging strategies, including targeted, immune checkpoint inhibitor, antibody-based, and combination therapies, in different patient populations with gynecologic cancer. Upon completion of this activity, participants should be better able to: Summarize the current treatment role of novel therapeutics, including in conjunction with modern molecular diagnostic testing, in gynecologic cancers, Describe updated evidence on new and emerging strategies, including targeted, immune checkpoint inhibitor, antibody-based, and combination therapies, in different patient populations with gynecologic cancers, Integrate approved and emerging options in the management of endometrial and cervical cancer, including in the context of clinical trials, based on disease characteristics and latest recommendations, Discuss the spectrum of unique safety considerations with novel targeted, antibody-based, and immunotherapy regimens in patients with gynecologic cancers.
Further episodes of PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
Further podcasts by PVI, PeerView Institute for Medical Education